Announced
Completed
Financials
Sources
Tags
Friendly
allergy solutions
Germany
Private
Single Bidder
Majority
pharmaceutical company
Pharmaceuticals
Acquisition
Completed
Synopsis
Dermapharm, a manufacturer of off-patent branded medicines, completed the acquisition of Allergopharma, an internationally operating pharmaceutical company specialized in in-vivo diagnosis and treatment, from Merck, a science and technology company. Financial terms were not disclosed. The transaction encompasses the Allergopharma business in Europe and Asia, including the therapeutic and diagnostic product portfolio as well as the production site in Reinbek near Hamburg. Allergopharma’s adrenaline autoinjector development project for the treatment of anaphylactic reactions is not part of the transaction and will remain with Merck KGaA, Darmstadt, Germany.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.